Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis
BioFactors · 2024
DOI: 10.1002/biof.2042 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Nevena Savic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Institute for Biological Research "Siniša Stanković," National Institute of Republic of Serbia, University of Belgra…. Hauptthemen laut MEDLINE: Ferroptosis, Isothiocyanates, Sulfoxides, NF-E2-Related Factor 2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Science Fund of the Republic of Serbia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Recently, we characterized the ferroptotic phenotype in the liver of diabetic mice and revealed nuclear factor (erythroid‐derived‐2)‐related factor 2 (Nrf2) inactivation as an integral part of hepatic injury. Here, we aim to investigate whether sulforaphane, an Nrf2 activator and antioxidant, prevents diabetes‐induced hepatic ferroptosis and the mechanisms involved. Male C57BL/6 mice were divided into four groups: control (vehicle‐treated), diabetic (streptozotocin‐induced; 40 mg/kg, from Days 1 to 5), diabetic sulforaphane‐treated (2.5 mg/kg from Days 1 to 42) and non‐diabetic sulforaphane‐treated group (2.5 mg/kg from Days 1 to 42). Results showed that diabetes‐induced inactivation of Nrf2 and decreased expression of its downstream antiferroptotic molecules critical for antioxidative defense (catalase, superoxide dismutases, thioredoxin reductase), iron metabolism (ferritin heavy chain (FTH1), ferroportin 1), glutathione (GSH) synthesis (cystine‐glutamate antiporter system, cystathionase, glutamate‐cysteine ligase catalitic subunit, glutamate‐cysteine ligase modifier subunit, glutathione synthetase), and GSH recycling ‐ glutathione reductase (GR) were reversed/increased by sulforaphane treatment. In addition, we found that the ferroptotic phenotype in diabetic liver is associated with increased ferritinophagy and decreased FTH1 immunopositivity. The antiferroptotic effect of sulforaphane was further evidenced through the increased level of GSH, decreased accumulation of labile iron and lipid peroxides (4‐hydroxy‐2‐nonenal, lipofuscin), decreased ferritinophagy and liver damage (decreased fibrosis, alanine aminotransferase, and aspartate aminotransferase). Finally, diabetes‐induced increase in serum glucose and triglyceride level was significantly reduced by sulforaphane. Regardless of the fact that this study is limited by the use of one model of experimentally induced diabetes, the results obtained demonstrate for the first time that sulforaphane prevents diabetes‐induced hepatic ferroptosis in vivo through the activation of Nrf2 signaling pathways. This nominates sulforaphane as a promising phytopharmaceutical for the prevention/alleviation of ferroptosis in diabetes‐related pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Institute for Biological Research "Siniša Stanković," National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
- Department of Cell and Tissue Biology, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
- Medical Biology Department, Centre Scientifique de Monaco (CSM), Monaco, Monaco.
ORCID-Profile: Nevena Savic, Ksenija Velickovic, Vesna Otasevic
Förderung
- The Ministry of Science, Technological Development and Innovation of the Republic of Serbia
- Science Fund of the Republic of Serbia
Zitieren
APA
Savic, N., Markelic, M., Stancic, A., Velickovic, K., Grigorov, I., Vucetic, M., Martinovic, V., Gudelj, A., & Otasevic, V. (2024). Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis. BioFactors. https://doi.org/10.1002/biof.2042
Vancouver
Savic N, Markelic M, Stancic A, Velickovic K, Grigorov I, Vucetic M, et al. Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis. BioFactors. 2024. doi:10.1002/biof.2042
BibTeX
@article{Savic2024,
author = {Savic, Nevena and Markelic, Milica and Stancic, Ana and Velickovic, Ksenija and Grigorov, Ilijana and Vucetic, Milica and Martinovic, Vesna and Gudelj, Andjelija and Otasevic, Vesna},
title = {Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis},
journal = {BioFactors},
year = {2024},
doi = {10.1002/biof.2042}
}
EUVIMED